Yanling Lu

75 Talavera Road
Macquarie Park, NSW 2113, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.

Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.

Journal: Urologic oncology

Published: April 23, 2023

Corrigendum to "Human Cardiac Myosin Binding Protein C: Structural Flexibility within an Extended Modular Architecture" [J. Mol. Biol. 414(5) (2011) 735-748].

Corrigendum to "Human Cardiac Myosin Binding Protein C: Structural Flexibility within an Extended Modular Architecture" [J. Mol. Biol. 414(5) (2011) 735-748].

Journal: Journal of molecular biology

Published: February 27, 2023

Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma.

Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma.

Journal: Molecular pharmaceutics

Published: January 05, 2023

Assessing the activity of antibodies conjugated to upconversion nanoparticles for immunolabeling.

Assessing the activity of antibodies conjugated to upconversion nanoparticles for immunolabeling.

Journal: Analytica chimica acta

Published: November 10, 2021

Upconversion nanoparticle-assisted single-molecule assay for detecting circulating antigens of aggressive prostate cancer.

Upconversion nanoparticle-assisted single-molecule assay for detecting circulating antigens of aggressive prostate cancer.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: July 14, 2021

Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers.

Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers.

Journal: Asia Oceania journal of nuclear medicine & biology

Published: February 16, 2021

Glypican-1 as a target for fluorescence molecular imaging of bladder cancer.

Glypican-1 as a target for fluorescence molecular imaging of bladder cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 12, 2020

The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.

The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.

Journal: Photodiagnosis and photodynamic therapy

Published: May 12, 2020

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab®-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery.

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab®-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery.

Journal: Cancers

Published: March 13, 2020

The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation.

The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation.

Journal: Nucleic acids research

Published: January 29, 2015

The role of heme binding by DNA-protective protein from starved cells (Dps) in the Tolerance of Porphyromonas gingivalis to heme toxicity.

The role of heme binding by DNA-protective protein from starved cells (Dps) in the Tolerance of Porphyromonas gingivalis to heme toxicity.

Journal: The Journal of biological chemistry

Published: October 23, 2012

The motif of human cardiac myosin-binding protein C is required for its Ca2+-dependent interaction with calmodulin.

The motif of human cardiac myosin-binding protein C is required for its Ca2+-dependent interaction with calmodulin.

Journal: The Journal of biological chemistry

Published: July 18, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026